Published in Virchows Arch on May 11, 2012
Whipple's Disease: Our Own Experience and Review of the Literature. Gastroenterol Res Pract (2013) 0.88
Host-Mycobacterium avium subsp. paratuberculosis interactome reveals a novel iron assimilation mechanism linked to nitric oxide stress during early infection. BMC Genomics (2013) 0.83
Apigenin induces the apoptosis and regulates MAPK signaling pathways in mouse macrophage ANA-1 cells. PLoS One (2014) 0.80
Social stress-enhanced severity of Citrobacter rodentium-induced colitis is CCL2-dependent and attenuated by probiotic Lactobacillus reuteri. Mucosal Immunol (2015) 0.80
Neuroimmunomodulation in the Gut: Focus on Inflammatory Bowel Disease. Mediators Inflamm (2016) 0.77
Colonic Carcinoma Associated with Malakoplakia. West Indian Med J (2014) 0.75
Whipple's disease in granulomatous disguise: a challenging diagnosis with many histopathological pitfalls. Virchows Arch (2017) 0.75
Non-labeling multiphoton excitation microscopy as a novel diagnostic tool for discriminating normal tissue and colorectal cancer lesions. Sci Rep (2017) 0.75
Unravelling the pathogenesis of inflammatory bowel disease. Nature (2007) 18.52
Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nat Rev Microbiol (2007) 7.36
Defective acute inflammation in Crohn's disease: a clinical investigation. Lancet (2006) 5.83
Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey. Eur J Clin Invest (2004) 4.54
Cystinosis. N Engl J Med (2002) 4.51
Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity. J Clin Invest (2005) 4.26
Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature. Medicine (Baltimore) (1990) 3.95
Intracellular and extracellular roles of S100 proteins. Microsc Res Tech (2003) 3.70
Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's disease. J Exp Med (2009) 3.58
Molecular characterization of a kinesin-related antigen of Leishmania chagasi that detects specific antibody in African and American visceral leishmaniasis. Proc Natl Acad Sci U S A (1993) 3.40
Disseminated histoplasmosis: clinical and pathologic correlations. Medicine (Baltimore) (1980) 3.35
Pompe's disease. Lancet (2008) 3.11
Phenotype, diagnosis, and treatment of Gaucher's disease. Lancet (2008) 3.06
Fabry's disease. Lancet (2008) 2.89
Whipple's disease: new aspects of pathogenesis and treatment. Lancet Infect Dis (2008) 2.78
Practice guidelines for the management of patients with histoplasmosis. Infectious Diseases Society of America. Clin Infect Dis (2000) 2.71
Acid sphingomyelinase deficient mice: a model of types A and B Niemann-Pick disease. Nat Genet (1995) 2.66
The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease. Arch Intern Med (2000) 2.63
Heterogeneity of HLA-DR-positive histiocytes in human intestinal lamina propria: a combined histochemical and immunohistological analysis. J Clin Pathol (1983) 2.49
Molecular diagnosis of leishmaniasis: current status and future applications. J Clin Microbiol (2006) 2.48
Non-typhoidal salmonellosis: emerging problems. Microbes Infect (2001) 2.44
Gastrointestinal histoplasmosis. Am J Gastroenterol (2005) 2.43
Cell surface expression of mouse macrosialin and human CD68 and their role as macrophage receptors for oxidized low density lipoprotein. Proc Natl Acad Sci U S A (1996) 2.32
Mycobacterial survival strategies in the phagosome: defence against host stresses. Cell Microbiol (2009) 2.18
Investigation of Crohn's disease risk loci in ulcerative colitis further defines their molecular relationship. Gastroenterology (2008) 2.17
Efficacy of ceftriaxone or meropenem as initial therapies in Whipple's disease. Gastroenterology (2009) 2.15
Macrophage specificity of three anti-CD68 monoclonal antibodies (KP1, EBM11, and PGM1) widely used for immunohistochemistry and flow cytometry. Ann Rheum Dis (2004) 2.09
The genetics of Crohn's disease. Annu Rev Genomics Hum Genet (2009) 2.07
Rhodococcus equi infection. Lancet Infect Dis (2010) 2.00
The pathogenesis and treatment of acid sphingomyelinase-deficient Niemann-Pick disease. J Inherit Metab Dis (2007) 1.94
Extrapulmonary pneumocystosis: the first 50 cases. Rev Infect Dis (1991) 1.89
Gastric siderosis: patterns and significance. Am J Surg Pathol (2006) 1.83
Intestinal macrophages and response to microbial encroachment. Mucosal Immunol (2010) 1.76
State of the art: histoplasmosis. Am Rev Respir Dis (1978) 1.73
The niemann-pick disease genes; regulators of cellular cholesterol homeostasis. Trends Cardiovasc Med (2004) 1.67
Transcription factors that regulate monocyte/macrophage differentiation. J Leukoc Biol (1998) 1.55
Mucosal IL-8 and TGF-beta recruit blood monocytes: evidence for cross-talk between the lamina propria stroma and myeloid cells. J Leukoc Biol (2006) 1.47
Rhodococcus equi infections in immunocompetent hosts: case report and review. Clin Infect Dis (2001) 1.47
Lysosomal storage diseases as disorders of autophagy. Autophagy (2007) 1.46
Lysosomal storage disease: revealing lysosomal function and physiology. Physiology (Bethesda) (2010) 1.42
Mucosal biopsy of the rectum, colon, and distal ileum. Hum Pathol (1982) 1.39
Inflammation anergy in human intestinal macrophages is due to Smad-induced IkappaBalpha expression and NF-kappaB inactivation. J Biol Chem (2010) 1.38
Use of genome selected repeated sequences increases the sensitivity of PCR detection of Tropheryma whipplei. J Clin Microbiol (2004) 1.36
Mesenteric mass in a young girl--an unusual site for Gaucher's disease. Pediatr Radiol (2002) 1.24
"Melanosis" in the small and large intestine. World J Gastroenterol (2008) 1.21
Failure of pulmonary clearance of Rhodococcus equi infection in CD4+ T-lymphocyte-deficient transgenic mice. Infect Immun (1993) 1.21
Histochemical and immunohistochemical characterization of foamy histiocytes (muciphages and xanthelasma) of the rectum. Am J Surg Pathol (2000) 1.21
Pathophysiologic and ultrastructural basis for intestinal symptoms in Fabry's disease. Gastroenterology (1982) 1.18
Gastrointestinal histoplasmosis in patients with AIDS: case report and review. Clin Infect Dis (2001) 1.17
Gastrointestinal pneumocystosis in HIV-infected patients on aerosolized pentamidine: report of five cases and literature review. Am J Gastroenterol (1992) 1.17
Role of T-lymphocyte subsets in Rhodococcus equi infection. Infect Immun (1992) 1.16
Cholesteryl ester storage disease and Wolman disease: phenotypic variants of lysosomal acid cholesteryl ester hydrolase deficiency. Am J Hum Genet (1984) 1.15
Hyperplastic polyp with epithelial misplacement (inverted hyperplastic polyp): a clinicopathologic and immunohistochemical study of 19 cases. Mod Pathol (2001) 1.15
Defects of monocyte interleukin 12 production and humoral immunity in Whipple's disease. Gastroenterology (1997) 1.13
The morphology of the normal human rectal biopsy. Hum Pathol (1972) 1.11
Pigment resembling atmospheric dust in Peyer's patches. Mod Pathol (1989) 1.10
Polypoid endometriosis: a clinicopathologic analysis of 24 cases and a review of the literature. Am J Surg Pathol (2004) 1.10
Persistent reduction of complement receptor 3 alpha-chain expressing mononuclear blood cells and transient inhibitory serum factors in Whipple's disease. Clin Immunol Immunopathol (1994) 1.10
Exogenous pigment in Peyer's patches. Hum Pathol (1987) 1.10
Rhodococcus equi can survive a phagolysosomal environment in macrophages by suppressing acidification of the phagolysosome. J Med Microbiol (2005) 1.10
Dysregulated peripheral and mucosal Th1/Th2 response in Whipple's disease. Gastroenterology (2002) 1.07
Normal histology of the colon. Am J Surg Pathol (1989) 1.07
The evaluation and treatment of gastrointestinal disease in children with cystinosis receiving cysteamine. J Pediatr (2003) 1.06
Mycobacterium avium subspecies paratuberculosis and its relationship with Crohn's disease. World J Gastroenterol (2009) 1.06
Tangier disease: still more questions than answers. Cell Mol Life Sci (2005) 1.04
Macrophage-specific gene expression: current paradigms and future challenges. Int J Hematol (2002) 1.03
Flow cytometric analysis of intracellular CD68 molecule expression in normal and malignant haemopoiesis. Br J Haematol (1995) 1.02
Characterisation of inorganic microparticles in pigment cells of human gut associated lymphoid tissue. Gut (1996) 1.01
Lysosomal dysfunction, cellular pathology and clinical symptoms: basic principles. Acta Paediatr Suppl (2006) 1.01
In vitro phagocytosis and killing of Corynebacterium equi by alveolar macrophages of foals. Am J Vet Res (1985) 0.94
Pathology of Tangier disease. J Clin Pathol (1971) 0.93
Diagnostic challenge of gastrointestinal tuberculosis: a report of 34 cases and an overview of the literature. Southeast Asian J Trop Med Public Health (2009) 0.93
Diagnosis of Wihipple disease by immunohistochemical analysis: a sensitive and specific method for the detection of Tropheryma whipplei (the Whipple bacillus) in paraffin-embedded tissue. Am J Clin Pathol (2002) 0.93
Molecular immunobiology of macrophages: recent progress. Curr Opin Immunol (1995) 0.92
Whipple's disease with esophageal and colonic involvement: endoscopic and histopathologic findings. Gastrointest Endosc (1997) 0.92
New insights into Whipple's disease and Tropheryma whipplei infections. Microbes Infect (2010) 0.91
Niemann-Pick disease. Curr Opin Hematol (2000) 0.89
Gastrointestinal histoplasmosis in suspected acquired immunodeficiency syndrome. West J Med (1985) 0.89
Malakoplakia of the appendix. An unusual association with eggs of Taenia species. Arch Pathol Lab Med (2000) 0.89
Intestinal tuberculosis: a diagnostic challenge--case report and review of the literature. Eur J Gastroenterol Hepatol (2011) 0.89
Malakoplakia of the colon in an infant with severe combined immunodeficiency (SCID) and charge association. Pathol Res Pract (2000) 0.88
Sea-blue histiocytosis secondary to Niemann-Pick disease type B: a case report. Ann Hematol (2001) 0.87
Unusual duodenal presentation of leishmaniasis. J Clin Pathol (2005) 0.87
New insights into gastrointestinal and hepatic granulomatous disorders. Nat Rev Gastroenterol Hepatol (2011) 0.87
Isolated xanthomatosis of the small bowel. Hum Pathol (1985) 0.87
Wolman disease and cholesteryl ester storage disease diagnosed by histological and ultrastructural examination of intestinal and liver biopsy. Pathol Res Pract (2004) 0.86
Macrophages from IBD patients exhibit defective tumour necrosis factor-α secretion but otherwise normal or augmented pro-inflammatory responses to infection. Immunobiology (2011) 0.86
Involvement of interferon-gamma and tumor necrosis factor-alpha in host defense against Rhodococcus equi. J Infect Dis (1993) 0.86
Multiple lipid islands of the colonic mucosa. A light and electron microscopic study. Pathol Res Pract (1988) 0.84
Massive gastrointestinal haemorrhage associated with ileal lymphoid hyperplasia in Gaucher's disease. Postgrad Med J (1991) 0.82
Colonic malakoplakia in a liver transplant recipient. Can J Gastroenterol (2007) 0.81
[Unusual presentation of visceral leishmaniasis in an immunocompetent patient]. Med Mal Infect (2006) 0.81
Lipid proctitis. N Engl J Med (1979) 0.81
The co-existence of Fabry and celiac diseases: a case report. Pediatr Nephrol (2004) 0.80
Infection by Rhodococcus equi in a patient with AIDS: histological appearance mimicking Whipple's disease and Mycobacterium avium-intracellulare infection. J Clin Pathol (1999) 0.80
Infection: How should classic Whipple disease be managed? Nat Rev Gastroenterol Hepatol (2010) 0.80
Gaucher's disease complicated by bleeding esophageal varices and colonic infiltration by Gaucher cells. Am J Gastroenterol (1991) 0.79
Colonic xanthomatosis. Relationship to disordered motility and review of the literature. Dig Dis Sci (1988) 0.78
Gaucher disease: new developments in treatment and etiology. World J Gastroenterol (2008) 0.78
Impaired monocyte function in patients successfully treated for Whipple's disease. Acta Gastroenterol Latinoam (1996) 0.77
Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol (2005) 10.16
Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease. N Engl J Med (2005) 6.33
A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology (2006) 3.68
ADAM10 cleavage of N-cadherin and regulation of cell-cell adhesion and beta-catenin nuclear signalling. EMBO J (2005) 2.95
Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease. Am J Gastroenterol (2002) 2.94
Amphiregulin and epiregulin mRNA expression in primary tumors predicts outcome in metastatic colorectal cancer treated with cetuximab. J Clin Oncol (2009) 2.92
The value of serologic markers in indeterminate colitis: a prospective follow-up study. Gastroenterology (2002) 2.58
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis. J Crohns Colitis (2012) 2.55
Adalimumab induces and maintains mucosal healing in patients with Crohn's disease: data from the EXTEND trial. Gastroenterology (2012) 2.03
The London Classification of gastrointestinal neuromuscular pathology: report on behalf of the Gastro 2009 International Working Group. Gut (2010) 1.89
Clinical usefulness of EGFR gene copy number as a predictive marker in colorectal cancer patients treated with cetuximab: a fluorescent in situ hybridization study. Clin Cancer Res (2008) 1.80
Atonal homolog 1 is a tumor suppressor gene. PLoS Biol (2009) 1.76
Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: a randomized, double-blind, placebo-controlled trial. Gastroenterology (2005) 1.73
Expression of apoptosis markers in the retinas of human subjects with diabetes. Invest Ophthalmol Vis Sci (2004) 1.73
Differential contribution of the three Aph1 genes to gamma-secretase activity in vivo. Proc Natl Acad Sci U S A (2005) 1.69
Defining thresholds of antibody levels improves diagnosis of celiac disease. Clin Gastroenterol Hepatol (2012) 1.55
Budesonide in collagenous colitis: a double-blind placebo-controlled trial with histologic follow-up. Gastroenterology (2002) 1.55
Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy. Eur Cytokine Netw (2006) 1.52
Liver receptor homolog 1 contributes to intestinal tumor formation through effects on cell cycle and inflammation. Proc Natl Acad Sci U S A (2005) 1.48
Gastrointestinal neuromuscular pathology: guidelines for histological techniques and reporting on behalf of the Gastro 2009 International Working Group. Acta Neuropathol (2009) 1.48
Long-term outcome after infliximab for refractory ulcerative colitis. J Crohns Colitis (2008) 1.36
Predictors of early response to infliximab in patients with ulcerative colitis. Inflamm Bowel Dis (2007) 1.33
Raman spectroscopy, a potential tool for the objective identification and classification of neoplasia in Barrett's oesophagus. J Pathol (2003) 1.31
Overexpression of indoleamine 2,3-dioxygenase in human inflammatory bowel disease. Clin Immunol (2004) 1.26
Impact of interval between neoadjuvant chemoradiotherapy and TME for locally advanced rectal cancer on pathologic response and oncologic outcome. Ann Surg Oncol (2012) 1.25
GCP-2/CXCL6 synergizes with other endothelial cell-derived chemokines in neutrophil mobilization and is associated with angiogenesis in gastrointestinal tumors. Exp Cell Res (2005) 1.24
Remission-inducing effect of anti-TNF monoclonal antibody in TNBS colitis: mechanisms beyond neutralization? Inflamm Bowel Dis (2007) 1.21
Gastric MALT lymphoma: a model of chronic inflammation-induced tumor development. Nat Rev Gastroenterol Hepatol (2010) 1.21
Cytokine profiles in aqueous humor of patients with different clinical entities of endogenous uveitis. Clin Immunol (2011) 1.20
Oral p38 mitogen-activated protein kinase inhibition with BIRB 796 for active Crohn's disease: a randomized, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol (2006) 1.20
Expression of MALT1 oncogene in hematopoietic stem/progenitor cells recapitulates the pathogenesis of human lymphoma in mice. Proc Natl Acad Sci U S A (2012) 1.19
Medical therapy for Crohn's disease strictures. Inflamm Bowel Dis (2004) 1.18
The role of CXC chemokines in the transition of chronic inflammation to esophageal and gastric cancer. Biochim Biophys Acta (2011) 1.18
Diagnostic accuracy of ten second-generation (human) tissue transglutaminase antibody assays in celiac disease. Clin Chem (2004) 1.17
MOHITO, a novel mouse cytokine-dependent T-cell line, enables studies of oncogenic signaling in the T-cell context. Haematologica (2010) 1.16
Mucosal gene expression of antimicrobial peptides in inflammatory bowel disease before and after first infliximab treatment. PLoS One (2009) 1.16
Citrullination of CXCL12 differentially reduces CXCR4 and CXCR7 binding with loss of inflammatory and anti-HIV-1 activity via CXCR4. J Immunol (2009) 1.15
Chemokines and gelatinases in the aqueous humor of patients with active uveitis. Am J Ophthalmol (2004) 1.15
Formation, distribution, and elimination of infliximab and anti-infliximab immune complexes in cynomolgus monkeys. J Pharmacol Exp Ther (2005) 1.13
Hypoxia in human colorectal adenocarcinoma: comparison between extrinsic and potential intrinsic hypoxia markers. Int J Radiat Oncol Biol Phys (2006) 1.12
Expression of hypoxia-inducible factor-1alpha and the protein products of its target genes in diabetic fibrovascular epiretinal membranes. Br J Ophthalmol (2007) 1.12
Critical role of stress in increased oesophageal mucosa permeability and dilated intercellular spaces. Gut (2007) 1.11
Prognostic value of serologic and histologic markers on clinical relapse in ulcerative colitis patients with mucosal healing. Am J Gastroenterol (2012) 1.11
Reciprocal changes of Foxp3 expression in blood and intestinal mucosa in IBD patients responding to infliximab. Inflamm Bowel Dis (2010) 1.10
The CXC chemokine GCP-2/CXCL6 is predominantly induced in mesenchymal cells by interleukin-1beta and is down-regulated by interferon-gamma: comparison with interleukin-8/CXCL8. Lab Invest (2003) 1.10
High-mobility group box-1 and biomarkers of inflammation in the vitreous from patients with proliferative diabetic retinopathy. Mol Vis (2011) 1.10
Mucosal gene expression of cell adhesion molecules, chemokines, and chemokine receptors in patients with inflammatory bowel disease before and after infliximab treatment. Am J Gastroenterol (2011) 1.10
Outcome after proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis. Inflamm Bowel Dis (2008) 1.10
JAK2 rearrangements, including the novel SEC31A-JAK2 fusion, are recurrent in classical Hodgkin lymphoma. Blood (2011) 1.09
Clinicopathologic comparison of plasmablastic lymphoma in HIV-positive, immunocompetent, and posttransplant patients: single-center series of 25 cases and meta-analysis of 277 reported cases. Am J Surg Pathol (2014) 1.09
Indeterminate colitis. Inflamm Bowel Dis (2003) 1.08
Infliximab induces apoptosis of monocytes and T lymphocytes in a human-mouse chimeric model. Clin Immunol (2005) 1.08
Efficacy of infliximab in refractory pouchitis and Crohn's disease-related complications of the pouch: a Belgian case series. Inflamm Bowel Dis (2010) 1.07
Erosive enterocolitis in mycophenolate mofetil-treated renal-transplant recipients with persistent afebrile diarrhea. Transplantation (2003) 1.06
Diagnostic performance of IgG anti-deamidated gliadin peptide antibody assays is comparable to IgA anti-tTG in celiac disease. Clin Chim Acta (2010) 1.05
Anti-IP-10 antibody (BMS-936557) for ulcerative colitis: a phase II randomised study. Gut (2013) 1.05
Caroli disease: review of eight cases with emphasis on magnetic resonance imaging features. Eur J Gastroenterol Hepatol (2011) 1.04
A pilot study on the use of the humanized anti-interleukin-2 receptor antibody daclizumab in active ulcerative colitis. Am J Gastroenterol (2003) 1.03
Protein-losing enteropathy in Crohn's disease. Acta Gastroenterol Belg (2007) 1.03
Predictive value of epithelial gene expression profiles for response to infliximab in Crohn's disease. Inflamm Bowel Dis (2010) 1.02
The value of myenteric plexitis to predict early postoperative Crohn's disease recurrence. Gastroenterology (2006) 1.02
Nodular lymphocyte predominant hodgkin lymphoma and T cell/histiocyte rich large B cell lymphoma--endpoints of a spectrum of one disease? PLoS One (2013) 1.02
Histology of microscopic colitis-review with a practical approach for pathologists. Histopathology (2015) 1.01
Loss of T cell microRNA provides systemic protection against autoimmune pathology in mice. J Autoimmun (2012) 1.00
A gamma-secretase inhibitor and quinacrine reduce prions and prevent dendritic degeneration in murine brains. Proc Natl Acad Sci U S A (2008) 0.98
CXCR1-binding chemokines in inflammatory bowel diseases: down-regulated IL-8/CXCL8 production by leukocytes in Crohn's disease and selective GCP-2/CXCL6 expression in inflamed intestinal tissue. Eur J Immunol (2004) 0.98
Circulating bone-marrow-derived endothelial precursor cells contribute to neovascularization in diabetic epiretinal membranes. Acta Ophthalmol (2011) 0.97
One-year outcome of biological and synthetic bioabsorbable meshes for augmentation of large abdominal wall defects in a rabbit model. J Surg Res (2013) 0.96
T-cell/histiocyte-rich large B-cell lymphoma shows transcriptional features suggestive of a tolerogenic host immune response. Haematologica (2009) 0.96
The activated form of gelatinase B/matrix metalloproteinase-9 is associated with diabetic vitreous hemorrhage. Exp Eye Res (2006) 0.96
Localized giant inflammatory polyp of the colon in a patient without inflammatory bowel disease. Virchows Arch (2011) 0.95
Effects of interleukin 4 on CD25+CD4+ regulatory T cell function. J Autoimmun (2005) 0.95
Evidence for the involvement of infectious agents in the pathogenesis of Crohn's disease. World J Gastroenterol (2008) 0.95
Serological diagnosis of celiac disease: comparative analysis of different strategies. Clin Chim Acta (2012) 0.95
PRDM1/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphoma. Blood (2013) 0.94
Systemic mastocytosis involving the gastrointestinal tract: clinicopathologic and molecular study of five cases. Mod Pathol (2008) 0.93
Effects of electrical stimulation or lesion in nucleus accumbens on the behaviour of rats in a T-maze after administration of 8-OH-DPAT or vehicle. Behav Brain Res (2003) 0.93
Decreased lymphatic vessel density is associated with postoperative endoscopic recurrence in Crohn's disease. Inflamm Bowel Dis (2013) 0.93
Surgical therapy and histological abnormalities in functional isolated small bowel obstruction and idiopathic gastrointestinal perforation in the very low birth weight infant. World J Surg (2003) 0.92
Molecular responses of rectal cancer to preoperative chemoradiation. Radiother Oncol (2006) 0.91
Serrated polyps of the colon: how reproducible is their classification? Virchows Arch (2012) 0.91
CXC chemokine expression profiles in aqueous humor of patients with different clinical entities of endogenous uveitis. Immunobiology (2011) 0.91
Expression of myofibroblast activation molecules in proliferative vitreoretinopathy epiretinal membranes. Acta Ophthalmol (2011) 0.91
Gastrointestinal motility changes and myenteric plexus alterations in spontaneously diabetic biobreeding rats. J Neurogastroenterol Motil (2013) 0.91
Expression of angiogenic and fibrogenic factors in proliferative vitreoretinal disorders. Int Ophthalmol (2007) 0.90
Single-center analysis of biopsy-confirmed posttransplant lymphoproliferative disorder: incidence, clinicopathological characteristics and prognostic factors. Leuk Lymphoma (2013) 0.90